Lubiprostone is a gastrointestinal drug used to treat chronic idiopathic constipation and irritable bowel syndrome with constipation. It is a chloride channel activator that works by increasing the secretion of fluid into the intestine, which helps to soften the stool and increase its passage through the intestines. It is available in capsule form and is taken orally. Lubiprostone is a relatively new drug, having been approved by the FDA in 2006. It is a prescription drug and is available in the United States, Canada, and Europe. It is generally well-tolerated, with the most common side effects being nausea, diarrhea, and abdominal pain. The lubiprostone market is a growing one, with increasing demand for the drug due to its effectiveness in treating chronic constipation and irritable bowel syndrome. It is a competitive market, with several companies offering the drug. Some of the companies in the market include Allergan, Ironwood Pharmaceuticals, and Sucampo Pharmaceuticals. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
